Shares of Britain-based pharmaceutical company GSK plc (GSK) — formerly known as GlaxoSmithKline — are sliding in pre-market trading and into Monday's...
) — formerly known as GlaxoSmithKline — are sliding in pre-market trading and into Monday's session open following a court ruling that has approved more than 70,000 lawsuits to go forward over heartburn medication Zantac 's alleged links to cancer.Shares of GSK they're plunging after a court ruling, stating the drug maker must face trials over claims that its heartburn medication, Zantac causes cancer.
But obviously, when you see a move to this extent here, like we're seeing today, there are some concerns at least short term, what exactly this is going to mean for a Glass E Smith client's business.Yeah, GSK expected to appeal and also they uh had put out a statement saying that the studies, oh, got that one.
Cathie Wood's ARK Invest missed out on more than $1 billion in returns by selling Nvidia stock too early America’s gummed-up housing market is a $45 trillion mess — a big old knot of economic forces smashing into a century’s worth of cultural conditioning about the value of homeownership.Missed NVIDIA? Check Out This Semiconductor AI Penny Stock
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
GSK Plunges as Drugmaker Must Face Zantac Cases in Delaware(Bloomberg) -- GSK Plc shares plunged in the wake of a court ruling that the UK drugmaker, alongside others including Sanofi, must face trials over whether...
Read more »
GSK Plunges as Drugmaker Must Face Zantac Cases in DelawareGSK Plc shares slumped in the wake of a court ruling that the UK drugmaker, alongside others including Sanofi, must face trials over whether the former heartburn treatment Zantac causes cancer.
Read more »
GSK Faces Whistleblower Suit From Lab That Found Zantac RiskGSK Plc is facing a whistleblower lawsuit that could potentially cost it billions of dollars from the laboratory that revealed the presence of a probable carcinogen in Zantac, the heartburn medication that the UK drugmaker invented and turned into a blockbuster.
Read more »
Delaware judge lets more than 70,000 Zantac lawsuits go forwardExplore stories from Atlantic Canada.
Read more »
Delaware judge lets more than 70,000 Zantac lawsuits go forwardExplore stories from Atlantic Canada.
Read more »
First Zantac Cancer Case to Go to Trial Ends in Win for DrugmakersDrugmakers GSK Plc and Boehringer Ingelheim GmbH persuaded a Chicago jury to reject a woman’s claim that the blockbuster heartburn drug Zantac caused her cancer, handing the companies a win in the first of thousands of such lawsuits to go to trial.
Read more »